Day: May 15, 2026

us corporate news

Galectin Therapeutics Reports Q1 2026 Financial Results and Advances Belapectin for MASH Cirrhosis with Positive NAVIGATE Trial Data 123

Minichart

May 15, 2026

Galectin Therapeutics Q1 2026 Financial Results and Business...

Continue Reading 0

us corporate news

Quaker Chemical Corporation (KWR) 8-K Filing Details: Company Information, SEC Compliance, and Contact Data

Minichart

May 15, 2026

Quaker Chemical Corporation (KWR) 8-K Filing: Key Details fo...

Continue Reading 0

us corporate news

Tandem Diabetes Care, Inc. Files Form 8-K with SEC Detailing Company Information and NASDAQ Listing

Minichart

May 15, 2026

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) Announces Terminat...

Continue Reading 0

us corporate news

Strategy Inc Files Form 8-K Announcing Preferred Stock Listing on NASDAQ

Minichart

May 15, 2026

Strategy Inc. Announces Repurchase of Convertible Notes – Ke...

Continue Reading 0

us corporate news

VerifyMe, Inc. Reports Q1 2026 Financial Results: Revenue Drops 60% but Gross Margin Improves to 54%

Minichart

May 15, 2026

VerifyMe, Inc. Q1 2026 Financial Results: Key Details for In...

Continue Reading 0

us corporate news

Lifeward Ltd. Closes Oratech Acquisition, Receives $10M Financing, Launches Phase 2 Oral Insulin Trial, and Expands Exoskeleton Technology for Stroke Rehabilitation

Minichart

May 15, 2026

Lifeward Ltd. Q1 2026 Financial Results – In-Depth Investor ...

Continue Reading 0

us corporate news

Enveric Biosciences Reports Q1 2026 Results, Advances Non-Hallucinogenic Antidepressant EB-003 Toward Clinical Trials

Minichart

May 15, 2026

Enveric Biosciences Q1 2026 Results & Corporate Update: Inve...

Continue Reading 0

us corporate news

Indaptus Therapeutics Reports Q1 2026 Financial Results, Management Changes, and Strategic Review Amid Cash Constraints

Minichart

May 15, 2026

Indaptus Therapeutics Reports Q1 2026 Financial Results and ...

Continue Reading 0

us corporate news

RenX Enterprises Reports Q1 2026 Results: Logistics Segment Turns Profitable, Revenue Grows 20.5% to $3.96M

Minichart

May 15, 2026

RenX Enterprises Corp. Reports Q1 2026 Results: Logistics Se...

Continue Reading 0

us corporate news

aTyr Pharma Reports Q1 2026 Results, Advances Efzofitimod Phase 3 for Pulmonary Sarcoidosis After FDA Meeting

Minichart

May 15, 2026

aTyr Pharma (Nasdaq: ATYR) First Quarter 2026 Results and Co...

Continue Reading 0